A
Anomer Bio develops novel biological tools and reagents for advanced life science research. The company focuses on creating high-quality chemical probes and assay kits for molecular biology applications. This platform enables researchers to accelerate discovery in areas like protein-ligand interactions and cellular signaling pathways.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Anomer Bio develops novel small molecule therapeutics targeting challenging protein-protein interactions (PPIs) in oncology and immunology. The company utilizes proprietary structural biology platforms to design highly selective and potent inhibitors against historically "undruggable" targets. This approach aims to create first-in-class medicines for diseases with high unmet medical need.